UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Using a market index as a benchmark offers transparency, comparability, and alignment with market performance, aiding consistent evaluations.
28,506 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A prominent analyst argues SpaceX could surge, but practical hurdles and private-market realities temper the enthusia...
Warren Buffett’s transition at Berkshire Hathaway ushers in a new era. Yet three longtime favorites—Apple, American E...
A long standing trading rule is gone, and it could change how millions of small investors trade. This shift may lift ...
Ciena’s stock faced a sharp one-day retreat even after solid results, revealing how AI infrastructure optimism can cl...
Rocket Lab has unveiled a bold $8 billion move by announcing a plan to acquire Iridium. This article breaks down what...
AI hype meets real-world finance. This article explains why I remain cautious on CoreWeave stock, with clear risks, n...
Meta just delivered a major update, but the stock still slid. This article explains what happened, why the move may b...
WM Technology MAPS is weighing a pivotal year. This guide breaks down the Q4 2025 earnings, what technology (maps) 20...
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Oil breaks through $119 as geopolitical risk spikes. This article explains why this nuclear energy stock may stand ou...
A Paychex executive recently sold a small stake, raising questions about the stock's direction. This article explains...